Alkem Laboratories Limited (BOM:539523)

Alkem Laboratories Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Total Valuation

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jul 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Market Capitalization	687,678	633,575	583,680	590,890	406,055	432,909
Market Cap Growth	12.78%	8.55%	-1.22%	45.52%	-6.20%	30.72%
Enterprise Value	672,823	610,260	555,235	573,042	400,038	427,311
Last Close Price	5752.85	5303.30	4833.02	4850.03	3305.99	3472.30

Price Ratios

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jul 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
PE Ratio	29.88	27.53	26.95	32.91	41.26	26.31
PS Ratio	4.67	4.31	4.50	4.67	3.50	4.07
PB Ratio	4.79	4.42	4.69	5.52	4.30	4.89
P/TBV Ratio	5.33	4.91	5.10	6.01	4.75	5.30
P/FCF Ratio	51.10	47.08	47.18	34.99	28.01	56.07
P/OCF Ratio	35.03	32.28	30.51	30.33	24.13	38.97

EV Ratios

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jul 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
EV/Sales Ratio	4.57	4.15	4.28	4.52	3.45	4.02
EV/EBITDA Ratio	22.67	20.31	22.55	25.73	25.17	21.24
EV/EBIT Ratio	25.88	23.26	25.80	29.13	30.32	24.51
EV/FCF Ratio	50.00	45.35	44.88	33.93	27.60	55.34

Financial Efficiency

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jul 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Debt / Equity Ratio	0.14	0.14	0.11	0.13	0.15	0.30
Debt / EBITDA Ratio	0.68	0.68	0.55	0.63	0.86	1.31
Debt / FCF Ratio	1.52	1.52	1.12	0.84	0.96	3.46
Net Debt / Equity Ratio	-0.20	-0.20	-0.22	-0.27	0.03	0.15
Net Debt / EBITDA Ratio	-0.98	-0.98	-1.11	-1.28	0.16	0.67
Net Debt / FCF Ratio	-2.19	-2.19	-2.20	-1.69	0.18	1.76
Asset Turnover	0.76	0.76	0.78	0.86	0.83	0.83
Inventory Turnover	1.63	1.63	1.76	1.92	1.79	1.61
Quick Ratio	1.67	1.67	1.69	1.68	0.94	0.70
Current Ratio	2.55	2.55	2.76	2.61	2.36	1.76
Return on Equity (ROE)	17.56%	17.56%	19.14%	17.98%	11.01%	20.48%
Return on Assets (ROA)	8.50%	8.50%	8.09%	8.38%	5.93%	8.52%
Return on Invested Capital (ROIC)	19.18%	20.36%	21.48%	20.07%	10.24%	17.85%
Return on Capital Employed (ROCE)	16.30%	16.30%	15.70%	17.00%	13.10%	18.80%

Yields

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jul 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Earnings Yield	3.35%	3.63%	3.71%	3.04%	2.42%	3.80%
FCF Yield	1.96%	2.12%	2.12%	2.86%	3.57%	1.78%
Dividend Yield	0.91%	1.00%	0.93%	0.83%	0.76%	0.98%
Payout Ratio	26.49%	26.66%	23.19%	29.96%	23.08%	25.43%
Buyback Yield / Dilution	-0.00%	-0.00%	-	-	-	-
Total Shareholder Return	0.91%	1.00%	0.93%	0.83%	0.76%	0.98%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 30, 2026

Data Sources Report a data error